| Vol. 14.20 – 23 May, 2023 |
| |
|
|
| To investigate the contribution of primitive HSCs to the hematopoietic stress response in the native environment, the authors used fate mapping and proliferation tracking mouse models. [Blood] |
|
|
|
| PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| Genetically barcoded genome editing of synthetic target arrays for lineage tracing zebrafish were used to screen for factors expressed by the sinusoidal vascular niche that altered the phylogenetic distribution of the HSC pool under native conditions. [Cell Reports] |
|
|
|
| Scientists analyzed RNAseq from mouse MLL-AF9 leukemic cells and bone marrow aspirates representing a diverse collection of pediatric AML samples and identified the E3 ubiquitin ligase TRIM13 as a target of CHAF1B-mediated transcriptional repression associated with leukemogenesis. [Blood Advances] |
|
|
|
| Through the metabolite screening comparing CD34+ AML cells and healthy hematopoietic stem/progenitor cells, investigators identified enhanced lysophosphatidic acid synthesis activity in AML. [Cancer Science] |
|
|
|
| Scientists detected the expression of SH3BGRL3 and circRNA_0010984 among genes with protein-coding function obtained from the TCGA database by qRT-PCR. They synthesized plasmid vectors and carried out cell experiments, including cell proliferation, cell cycle, and cell differentiation by cell transfection. [Frontiers in Cell and Developmental Biology] |
|
|
|
| Researchers modulated WNT, Activin/Nodal, and MAPK signaling pathways by stage-specific addition of small molecule regulators CHIR99021, SB431542, and LY294002, respectively, and measured the impact on hematoendothelial formation in culture. [Stem Cells] |
|
|
|
| The authors investigated the effects of pinostrobin (PN) on proliferation inhibition and induction of apoptosis, as well as the involvement of miRNAs in PN-mediated apoptosis in acute leukemia. [Scientific Reports] |
|
|
|
| Investigators used RNA-seq to study the clinical significance of MYB expression and MYB alternative promoter (TSS2) usage in 133 pediatric acute lymphoblastic leukemia. RNA-seq revealed that all cases analyzed overexpressed MYB and demonstrated MYB TSS2 activity. [Genes Chromosomes & Cancer] |
| |
|
|
| Scientists performed germline and somatic targeted sequencing in a large cohort of adult patients with cytopenia and hypoplastic bone marrow to study germline predisposition variants and their clinical correlates. [Blood] |
|
|
|
| To evaluate the prognostic impact of complex karyotype and/or monosomal karyotype on allogeneic stem cell transplantation (HSCT) outcomes of patients with AML, researchers analyzed the registry database of adult AML patients who underwent allogeneic HSCT between 2000 and 2019 in Japan. [British Journal of Haematology] |
| |
|
|
|
| The authors summarize telomere and telomerase biology as it relates to both physiologic and malignant cells. They discuss the development of telomere and telomerase targeted therapeutic candidates within the realm of myeloid malignancies. [Blood Advances] |
|
|
|
| Investigators focus on recent progress in identifying the biological functions of m6A mRNA modification, its regulators, and downstream gene targets during normal and pathological hematopoiesis. [Journal of Leukocyte Biology] |
|
|
|
| Scientists summarize the research on the hematopoietic microenvironment of aplastic anemia (AA) in recent years to provide new ideas for the clinical treatment of AA. [European Journal of Haematology] |
|
|
|
|
| The University of Texas MD Anderson Cancer Center was awarded more than $5.7 million in grants from Break Through Cancer to support collaborative research teams working to discover novel molecular targets to eradicate minimal residual disease in AML and to treat clonal hematopoiesis. [The University of Texas MD Anderson Cancer Center] |
|
|
|
|
| June 2 – 6, 2023 Chicago, Illinois, United States |
|
|
|
|
|
| University of Texas MD Anderson Cancer Center – Houston, Texas, United States |
|
|
|
| The University of British Columbia – Vancouver, British Columbia, Canada |
|
|
|
| Fox Chase Cancer Center – Philadelphia, Pennsylvania, United States |
|
|
|
| Centre for Oncology and Immunology – Hong Kong, Hong Kong |
|
|
|
| University of Texas Health Science Centre – San Antonio, Texas, United States |
|
|
|
|